MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Twelve-week sensor assessment in Parkinson’s disease: Impact on quality of life

J.M.T. Van Uem, K.S. Maier, A.T. Santos, O. Fagerbakke, F. Larsen, J.J. Ferreira, W. Maetzler (Tübingen, Germany)

Meeting: 2016 International Congress

Abstract Number: 537

Keywords: Dyskinesias, Locomotion, Tremors: Clinical features

Session Information

Date: Monday, June 20, 2016

Session Title: Quality of life/caregiver burden in movement disorders

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To evaluate the effects of using wearables over a long time period on Health-Related Quality of Life (HRQoL) in Parkinson’s disease (PD) patients.

Background: Wearable systems such as body-worn sensors used in the domestic environment have the potential to revolutionise the assessment of PD. At present, it is not well understood which factors influence the motivation of PD patients to use wearables. Therefore we ran a multicentre 12-week observational study with patients wearing a SENSE-PARK sensor system 24/7 in their home environment.

Methods: Twenty-two PD patients (8 female, 14 male: mean age 60.7 years) were assigned to either the SENSE-PARK sensor system group (S-PD) or the non-sensor group (NS-PD). The SENSE-PARK assesses daytime (three sensors) and night-time (one sensor) movements. In the last eight weeks of the study, the S-PD group received daily feedback on the following features: tremor, dyskinesia/ hypokinesia, and gait. HRQoL was assessed at baseline and after 4, 12, and 14 weeks, using the Parkinson’s disease Questionnaire-39 (PDQ-39). Delta HRQoL scores were calculated by subtracting follow-up scores from baseline scores. The primary outcome measure was the delta PDQ-Summary Index (SI); secondary outcome variables were deltas of the PDQ-mobility and PDQ-Activities of Daily Living (ADL) scores.

Results: The primary outcome was not significantly different between the two groups. The secondary outcomes indicated that the S-PD group improved in the PDQ-mobility domain: this approached significance at the end of the sensor-wearing phase and was significant at follow-up (Figure 1, Table 1, 2).

Table 1
  Delta week 4 to baseline S-PD Delta week 4 to baseline NS-PD Delta week 12 to baseline S-PD Delta week 12 to baseline NS-PD Delta week 14 to baseline S-PD Delta week 14 to baseline NS-PD
PDQ-SI 1.76 2.19 3.77 3.50 2.56 4.17
PDQ-MOB 0.77 -0.50 4.78 -2.00 4.78 -2.92
PDQ-ADL 5.29 0.98 9.47 2.55 4.18 1.81
Delta values between the different visits: ‘No feedback’ (week 4- baseline), ‘With feedback’ (week 12- baseline), and ‘Follow-up’ (week 14- baseline). Positive numbers reflect improvement. NS-PD, Non-Sensor wearing group, PDQ-ADL, Parkinson’s disease Questionnaire-39 Activities of Daily Living domain, PDQ-MOB, Parkinson’s disease Questionnaire-39 Mobility domain, PDQ-SI, Parkinson’s disease Questionnaire-39 Summery Index, S-PD, sensor wearing group.”

Table 2
  Week 4 to baseline S-PD VS NS-PD Week 12 to baseline S-PD VS NS-PD Week 14 to baseline S-PD VS NS-PD
PDQ-SI 0.88 0.94 0.71
PDQ-MOB 0.52 0.09 0.04
PDQ-ADL 0.33 0.23 0.69
Comparison of the two cohorts using the delta values between the different visits: ‘No feedback’ (week 4- baseline), ‘With feedback’ (week 12- baseline), and ‘Follow-up’ (week 14- baseline), in a t-test. Positive numbers reflect improvement. NS-PD, Non-Sensor wearing group, PDQ-ADL, Parkinson’s disease Questionnaire-39 Activities of Daily Living domain, PDQ-MOB, Parkinson’s disease Questionnaire-39 Mobility domain, PDQ-SI, Parkinson’s disease Questionnaire-39 Summery Index, S-PD, sensor wearing group.“

Conclusions: Our main finding –no significant change in overall perceived HRQoL during a long observation period– indicates that it is possible to use wearables for the assessment of PD symptoms in the home environment. The significant improvement in the PDQ-mobility domain at the end of the study in the S-PD cohort indicates that the provision of feedback from sensor data to the users underlies this increase. Feedback appears to enhance motivation of the users to wear such technology. Our results justify a further investigation of the influence of the continuous and long-term use of wearables for the assessment of PD symptoms.

To cite this abstract in AMA style:

J.M.T. Van Uem, K.S. Maier, A.T. Santos, O. Fagerbakke, F. Larsen, J.J. Ferreira, W. Maetzler. Twelve-week sensor assessment in Parkinson’s disease: Impact on quality of life [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/twelve-week-sensor-assessment-in-parkinsons-disease-impact-on-quality-of-life/. Accessed May 21, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/twelve-week-sensor-assessment-in-parkinsons-disease-impact-on-quality-of-life/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley